© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Quest Diagnostics Incorporated (DGX) stock surged +0.26%, trading at $196.10 on NYSE, up from the previous close of $195.60. The stock opened at $195.57, fluctuating between $193.81 and $197.03 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Mar 24, 2026 | 194.58 | 197.03 | 193.81 | 196.08 | 757.44K |
| Mar 23, 2026 | 197.33 | 202.91 | 195.23 | 195.60 | 881.02K |
| Mar 20, 2026 | 194.07 | 196.83 | 192.79 | 195.26 | 1.96M |
| Mar 19, 2026 | 195.01 | 197.21 | 193.91 | 194.16 | 801.8K |
| Mar 18, 2026 | 197.07 | 201.49 | 194.88 | 195.23 | 694K |
| Mar 17, 2026 | 200.70 | 200.70 | 197.18 | 198.61 | 791.29K |
| Mar 16, 2026 | 200.98 | 201.88 | 198.86 | 198.94 | 776.21K |
| Mar 13, 2026 | 202.84 | 205.00 | 199.09 | 199.70 | 659.13K |
| Mar 12, 2026 | 200.34 | 203.00 | 199.97 | 200.88 | 772.78K |
| Mar 11, 2026 | 199.99 | 201.71 | 198.37 | 200.56 | 642.98K |
| Mar 10, 2026 | 203.15 | 204.39 | 198.87 | 200.90 | 675.82K |
| Mar 09, 2026 | 198.25 | 202.48 | 195.39 | 201.58 | 792.76K |
| Mar 06, 2026 | 203.76 | 203.78 | 199.01 | 199.21 | 1.05M |
| Mar 03, 2026 | 207.73 | 209.83 | 203.89 | 208.36 | 779.24K |
| Mar 02, 2026 | 212.52 | 213.26 | 209.43 | 210.25 | 921.99K |
| Feb 27, 2026 | 211.09 | 213.50 | 208.97 | 211.91 | 1.06M |
| Feb 26, 2026 | 208.67 | 211.56 | 208.09 | 211.10 | 783.72K |
| Feb 25, 2026 | 209.52 | 210.69 | 206.13 | 207.80 | 798.31K |
| Feb 24, 2026 | 207.81 | 209.90 | 206.36 | 209.54 | 882.08K |
| Feb 23, 2026 | 201.99 | 207.72 | 201.99 | 207.43 | 782.34K |
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
| Employees | 55000 |
| Beta | 0.63 |
| Sales or Revenue | $9.87B |
| 5Y Sales Change% | 0.492% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |